Measuring patient-reported physical functioning and fatigue in myelodysplastic syndromes using a modular approach based on EORTC QLQ-C30

[11] Johnson LL(1982)Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 649-788

[12] Donoghue M(1993)Assessment of quality of life and benefits from adjuvant therapies in breast cancer Recent Results Cancer Res 127 201-undefined

[13] Kwitkowski VE(2011)Rating scales and Rasch measurement Expert Rev Pharmacoecon Outcomes Res 11 571-undefined

[14] Chen WH(2009)Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods Health Technol Assess 13 iii, ix-x, 1–177-undefined

[15] Sridhara R(2016)Development of an item bank for the EORTC role functioning computer adaptive test (EORTC RF-CAT) Health Qual Life Outcomes 14 72-undefined

[16] Farrell AT(2001)QOL-E: A new tool for the assessment of quality of life (QOL) in myelodysplastic syndrome (MDS) Blood 98 427a-undefined

[17] Keegan P(2016)Prospective international validation of the quality of life in myelodysplasia scale (QUALMS) Haematologica. 101 781-undefined

[18] Kim G(undefined)undefined undefined undefined undefined-undefined

[19] Pazdur R(undefined)undefined undefined undefined undefined-undefined

[20] Kluetz PG(undefined)undefined undefined undefined undefined-undefined

[11] Johnson LL(1982)Toxicity and response criteria of the eastern cooperative oncology group Am J Clin Oncol 5 649-788

[12] Donoghue M(1993)Assessment of quality of life and benefits from adjuvant therapies in breast cancer Recent Results Cancer Res 127 201-undefined

[13] Kwitkowski VE(2011)Rating scales and Rasch measurement Expert Rev Pharmacoecon Outcomes Res 11 571-undefined

[14] Chen WH(2009)Improving the evaluation of therapeutic interventions in multiple sclerosis: the role of new psychometric methods Health Technol Assess 13 iii, ix-x, 1–177-undefined

[15] Sridhara R(2016)Development of an item bank for the EORTC role functioning computer adaptive test (EORTC RF-CAT) Health Qual Life Outcomes 14 72-undefined

[16] Farrell AT(2001)QOL-E: A new tool for the assessment of quality of life (QOL) in myelodysplastic syndrome (MDS) Blood 98 427a-undefined

[17] Keegan P(2016)Prospective international validation of the quality of life in myelodysplasia scale (QUALMS) Haematologica. 101 781-undefined

[18] Kim G(undefined)undefined undefined undefined undefined-undefined

[19] Pazdur R(undefined)undefined undefined undefined undefined-undefined

[20] Kluetz PG(undefined)undefined undefined undefined undefined-undefined